FNY Managed Accounts’s Kite Pharma, Inc. KITE Stock Holding History

FNY Managed Accounts's KITE Position: Q2 2017 in Review

FNY Managed Accounts sold out of Kite Pharma, Inc. (KITE) in Q2 2017, closing a stake of 180 shares — an estimated $14K sold.

FNY Managed Accounts first reported a position in KITE in Q1 2017 and held it in 1 quarter. The position peaked at $14K in Q1 2017. 220 funds tracked by Wall St. Rank hold KITE as of Q2 2017.

• FNY Managed Accounts reported no remaining Kite Pharma, Inc. position as of Q2 2017 after selling out during the quarter.
• FNY Managed Accounts sold 180 Kite Pharma, Inc. shares in Q2 2017, an estimated $14K.
• FNY Managed Accounts first reported a position in Kite Pharma, Inc. in Q1 2017 and held it in 1 quarter.
• FNY Managed Accounts's Kite Pharma, Inc. position peaked at $14K in Q1 2017.
• 220 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.